ArticlePLOS digital health2026
Reconstructing 12-lead ECG from 3-lead ECG using variational autoencoder to improve cardiac disease detection of wearable ECG devices.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Twelve-lead electrocardiograms (ECGs) are the clinical gold standard for cardiac diagnosis, offering comprehensive spatial coverage of the heart necessary for detecting conditions such as myocardial infarction (MI). However, their lack of portability limits continuous and large-scale deployment. In contrast, three-lead ECG systems are widely used in wearable devices due to their simplicity and mobility, but they often fail to capture pathologies localized in unmeasured regions. To bridge this gap, we propose WearECG, a Variational Autoencoder (VAE) method that reconstructs 12-lead ECGs from three leads (II, V1, V5). Our model includes architectural improvements to better capture temporal and spatial dependencies in ECG signals. We evaluate generation quality using MSE, MAE, and Fréchet Inception Distance (FID), and assess clinical validity via a Turing test with expert cardiologists. To further validate the diagnostic utility, we fine-tune ECGFounder-a large-scale pretrained ECG model-on a multi-label classification task involving over 40 cardiac conditions, including 6 different myocardial infarction locations using both real and generated signals. Experiments on the MIMIC and PTB-XL datasets show that our method produces physiologically realistic and diagnostically informative signals, with robust performance in downstream tasks. This work demonstrates the potential of generative modeling for ECG reconstruction and its implications for scalable, low-cost cardiac screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.